Abivax Socit Anonyme Stock Revenue
| AAVXF Stock | USD 11.05 0.00 0.00% |
ABIVAX Socit Anonyme fundamentals help investors to digest information that contributes to ABIVAX Société's financial success or failures. It also enables traders to predict the movement of ABIVAX Pink Sheet. The fundamental analysis module provides a way to measure ABIVAX Société's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ABIVAX Société pink sheet.
ABIVAX |
ABIVAX Socit Anonyme Company Revenue Analysis
ABIVAX Société's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current ABIVAX Société Revenue | 37 K |
Most of ABIVAX Société's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ABIVAX Socit Anonyme is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, ABIVAX Socit Anonyme reported 37 K of revenue. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The revenue for all United States stocks is 100.0% higher than that of the company.
ABIVAX Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ABIVAX Société's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of ABIVAX Société could also be used in its relative valuation, which is a method of valuing ABIVAX Société by comparing valuation metrics of similar companies.ABIVAX Socit is currently under evaluation in revenue category among its peers.
ABIVAX Fundamentals
| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 | |||
| Operating Margin | 4.66 % | |||
| Current Valuation | 165.28 M | |||
| Shares Outstanding | 22.3 M | |||
| Shares Owned By Insiders | 4.67 % | |||
| Shares Owned By Institutions | 57.27 % | |||
| Price To Earning | (7.88) X | |||
| Price To Book | 27.57 X | |||
| Price To Sales | 20.65 X | |||
| Revenue | 37 K | |||
| Gross Profit | (45.52 M) | |||
| EBITDA | (42.25 M) | |||
| Net Income | (41.36 M) | |||
| Cash And Equivalents | 26.57 M | |||
| Cash Per Share | 1.58 X | |||
| Total Debt | 53.45 M | |||
| Debt To Equity | 8.03 % | |||
| Current Ratio | 2.03 X | |||
| Book Value Per Share | 0.36 X | |||
| Cash Flow From Operations | (45.66 M) | |||
| Earnings Per Share | (2.59) X | |||
| Number Of Employees | 24 | |||
| Beta | 1.26 | |||
| Market Capitalization | 165.36 M | |||
| Total Asset | 110.36 M | |||
| Z Score | 1.8 | |||
| Net Asset | 110.36 M |
About ABIVAX Société Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ABIVAX Socit Anonyme's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABIVAX Société using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABIVAX Socit Anonyme based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ABIVAX Pink Sheet
ABIVAX Société financial ratios help investors to determine whether ABIVAX Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABIVAX with respect to the benefits of owning ABIVAX Société security.